[{"Assets_0_Q1_USD":9803324000.0,"CommonStockSharesConverted_0_Q1_shares":224864678.0,"CommonStockSharesOutstanding_0_Q1_shares":224864678.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-90583000.0,"NetIncomeLossConverted_1_Q1_USD":-18573000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":224594000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":224594000.0,"StockholdersEquity_0_Q1_USD":-494450000.0,"EarningsPerShareBasic_1_Q1_USD":-0.08,"EarningsPerShareDiluted_1_Q1_USD":-0.08,"RevenuesConverted_1_Q1_USD":720411000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]